NCT02075658 - A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 31, 2014

Study Completion Date

September 30, 2014

Conditions

Renal Cell Carcinoma

Interventions

DEVICE

AirSeal® System-Interventional

The AirSeal® System consists of an insufflation, filtration, and recirculation system (AirSeal® IFS), a triple lumen filtered tube set, and a valve free trocar (AirSeal® Access Port). The device enables peritoneal access with a novel mechanism to maintain pneumoperitoneum without a mechanical seal.

DEVICE

Conventional Insufflator and Trocar

Conventional insufflator and trocars are used in standard procedures and will serve as the base for comparison of the study device (AirSeal® System).

Trial Locations (1)

92868

University of California, Irvine Medical Center, Orange

All Listed Sponsors

lead

University of California, Irvine

OTHER